AustralianSuper Pty Ltd lessened its stake in MetLife, Inc. (NYSE:MET - Free Report) by 7.1% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 1,851,266 shares of the financial services provider's stock after selling 140,432 shares during the quarter. AustralianSuper Pty Ltd owned 0.27% of MetLife worth $151,582,000 as of its most recent filing with the SEC.
Other institutional investors and hedge funds have also made changes to their positions in the company. PFG Investments LLC lifted its holdings in MetLife by 8.9% during the 3rd quarter. PFG Investments LLC now owns 6,360 shares of the financial services provider's stock worth $525,000 after buying an additional 520 shares during the last quarter. CX Institutional lifted its position in shares of MetLife by 15.9% during the 4th quarter. CX Institutional now owns 68,005 shares of the financial services provider's stock worth $5,568,000 after buying an additional 9,337 shares during the last quarter. B. Metzler seel. Sohn & Co. Holding AG acquired a new position in shares of MetLife in the 3rd quarter valued at $2,960,000. Meeder Asset Management Inc. grew its position in shares of MetLife by 48,101.4% in the 3rd quarter. Meeder Asset Management Inc. now owns 106,043 shares of the financial services provider's stock valued at $8,746,000 after buying an additional 105,823 shares during the last quarter. Finally, Segall Bryant & Hamill LLC purchased a new stake in shares of MetLife in the 3rd quarter valued at about $1,074,000. 94.99% of the stock is owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
A number of research analysts recently weighed in on MET shares. TD Cowen upped their price objective on MetLife from $97.00 to $99.00 and gave the stock a "buy" rating in a report on Wednesday, November 27th. StockNews.com cut shares of MetLife from a "buy" rating to a "hold" rating in a research report on Thursday, January 9th. Wells Fargo & Company increased their price objective on shares of MetLife from $92.00 to $97.00 and gave the company an "overweight" rating in a research report on Wednesday. JPMorgan Chase & Co. raised their price target on shares of MetLife from $86.00 to $88.00 and gave the stock an "overweight" rating in a research report on Tuesday, January 7th. Finally, Barclays lowered their price objective on MetLife from $96.00 to $95.00 and set an "overweight" rating for the company in a report on Friday, February 7th. Two research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and an average price target of $92.58.
Check Out Our Latest Stock Report on MET
MetLife Price Performance
Shares of NYSE MET traded up $0.65 during trading on Wednesday, reaching $83.08. The company had a trading volume of 2,818,589 shares, compared to its average volume of 3,652,965. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.16 and a current ratio of 0.16. The business's 50 day moving average price is $83.41 and its 200-day moving average price is $81.23. MetLife, Inc. has a 52 week low of $67.30 and a 52 week high of $89.05. The stock has a market cap of $57.53 billion, a PE ratio of 13.92, a PEG ratio of 0.64 and a beta of 1.07.
MetLife (NYSE:MET - Get Free Report) last posted its quarterly earnings results on Wednesday, February 5th. The financial services provider reported $2.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.13 by ($0.05). MetLife had a return on equity of 20.42% and a net margin of 6.19%. Analysts expect that MetLife, Inc. will post 9.66 earnings per share for the current year.
MetLife Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 11th. Stockholders of record on Tuesday, February 4th will be paid a dividend of $0.545 per share. The ex-dividend date of this dividend is Tuesday, February 4th. This represents a $2.18 dividend on an annualized basis and a dividend yield of 2.62%. MetLife's dividend payout ratio is 36.52%.
About MetLife
(
Free Report)
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Featured Articles
Before you consider MetLife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.
While MetLife currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
